EHMT1 and cancer: The resulting hybrid derivatives turned out to be very potent against GLP and HDAC1/6 enzymes with nanomolar IC50 values (IC50 < 190 nM) and cytotoxic against several cancer cell lines with micromolar IC50 values (IC50 < 50 μM) (Table 27 and Table 28).